CEimpact Podcast artwork

Thrombolytic Use in Persons with Stroke and Direct Oral Anticoagulants

CEimpact Podcast

English - February 13, 2023 05:00 - 27 minutes - 19 MB
Courses Education Science ceimpact podcast precept2practice level up gamechangers pharmacy cme cpe pharmacology ceimpact geoff wall Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed


Patient use of any anticoagulation during an acute stroke is a contraindication for the use of thrombolytics or clot busters. Recent meta-analyses and animal studies raise the question of this contraindication. Join guest, Geoff Wall, as he examines the data on Direct Oral Anticoagulants (DOACs) and thrombolytics.

The GameChanger
DOACs have a significantly smaller intracranial hemorrhage (ICH) risk compared to warfarin and this benefit may translate to risk of bleed with thrombolytics. A new study found a numerically decreased risk of ICH in patients with DOACs compared to controls.

Show Segments
00:00 - Introductions
01:07 - Current Practices with Thrombolytics
05:05 - Looking at the Study
19:45 - The GameChanger: Decreased ICH Risk?
23:30 - Study Limitations
26:11 - Connecting to Practice
27:01 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources
Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants

Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:

1. Discuss the theory about why DOACs may not increase risk of intracranial bleed in stroke patients receiving thrombolytics
2. Describe the limitations of the Meinel et al study

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-064-H01-P
Initial release date: 02/13/2023
Expiration date: 02/13/2024
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram